IconicAlpha
← Back to the wall
Bio-Techne Corporation

Bio-Techne Corporation

TECH · Healthcare · Life Sciences Tools & Services

Market cap
$11.4B
Price
$72.74
Daily change
+0.07%
Rank
#461

Updated 24 min ago · data delayed ≥15 min

IconicScore

Proprietary
31/ 100
Scale10
Momentum51
Sector leadership8
Brand visibility75

Ranked #479 of 500 by Iconic Score · #55 of 59in its sector. IconicAlpha’s proprietary brand-intelligence metric — a multi-model blend of scale, market attention, category leadership, and AI-analyzed brand visibility.

Score trend · 88d+14 pts
Free · every trading day, 7 AM ET

Get the free morning email

The biggest IconicScore™ gainer and loser, plus the strongest and weakest sectors, in your inbox before the open. See a sample →

Price performance

Export history · Analyst
Price$72.74+35.9%
$73$43
Apr 26Oct 26
IconicScore vs. price

This insight is part of the Analyst tier — unlock the IconicScore vs. price overlay, side-by-side comparison, and CSV export.

Upgrade to Analyst
Sector benchmark

This is part of the Enterprise tier — benchmark your IconicScore against sector peers, claim your profile, and manage how your brand appears on the wall.

Upgrade to Enterprise

Iconic Profile

Bio-Techne Corp (TECH) is a leading provider of life sciences tools and services, specializing in the development and manufacturing of high-quality reagents, instruments, and consumables for research and clinical applications. With a market capitalization of $11.2 billion, the company serves a diverse range of customers in the biotechnology, pharmaceutical, and academic sectors, positioning itself as a critical player in the advancement of scientific research and diagnostics. Bio-Techne's extensive portfolio includes proteins, antibodies, and assays, which are essential for drug discovery, development, and personalized medicine. The company's commitment to innovation and quality has established it as a trusted partner in the life sciences community, making it a significant contributor to advancements in healthcare and research methodologies.

IconicOracleAI™ Brief

Bio-Techne Corp's Iconic Score of 31 reflects a moderate brand perception, influenced by recent headlines highlighting the opening of a new GMP small molecule facility in Bristol, UK. This expansion of their global manufacturing network is aimed at enhancing scalable cell therapy development, which may contribute positively to brand visibility. Despite these developments, the overall sentiment remains subdued, as indicated by the company's relatively low score and the mixed attention from market commentary.

AI-generated explanation of current score drivers. Not investment advice.

Visit website ↗Compare ⇄Claim this profile

Enterprise tier: claim your logo to manage how your brand is represented.